COMBINATIONS OF ADRENERGIC RECEPTOR AGONISTS FOR THE TREATMENT OF TYPE 2 DIABETES

摘要

There is herein provided pharmaceutical formulations and kits-of-parts comprising a β₂-adrenergic receptor agonist, or a pharmaceutically acceptable salt thereof, and a β₃-adrenergic receptor agonist, or a pharmaceutically acceptable salt thereof. This combination of active agents finds particular utility in the treatment of type 2 diabetes.